Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity.
A. Garcia
Disclosure not yet available
A. Awada
Disclosure not yet available
S. Chan
Disclosure not yet available
G. H. M. Jerusalem
Disclosure not yet available
R. E. Coleman
Disclosure not yet available
M. T. Huizing
Disclosure not yet available
A. Mehdi
Disclosure not yet available
S. M. O'Reilly
Disclosure not yet available
J. T. Hamm
Disclosure not yet available
P. J. Barrett-Lee
Disclosure not yet available
V. Cocquyt
Disclosure not yet available
K. Sideras
Disclosure not yet available
D. E. Young
Disclosure not yet available
M. Brown
Disclosure not yet available
C. Zhao
Disclosure not yet available
A. L. Hannah
Disclosure not yet available
A. C. F. Leung
Disclosure not yet available
L. K. Masuoka
Disclosure not yet available
E. A. Perez
Disclosure not yet available